| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/04/1999 | WO1999005183A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
| 02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 02/04/1999 | WO1999005161A1 HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
| 02/04/1999 | WO1999004825A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/04/1999 | WO1999004819A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | WO1999004812A1 Nucleic acid based immunotherapy of chronic hepatitis b infection |
| 02/04/1999 | WO1999004810A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | WO1999004806A1 Methods and compositions for inhibiting angiogenesis |
| 02/04/1999 | WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | WO1999004636A1 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 02/04/1999 | WO1998050079A3 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes |
| 02/04/1999 | WO1998048821A3 Use of conantokins for producing analgesia or for neuroprotection |
| 02/04/1999 | DE19733364A1 Verfahren zur Klonierung eines großen Virusgenoms Method for cloning a large viral genome |
| 02/04/1999 | CA2732570A1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | CA2305624A1 Recombinant lysostaphin analogs |
| 02/04/1999 | CA2301166A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | CA2298474A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/04/1999 | CA2298410A1 Intracellular inhibitors of gq protein signaling |
| 02/04/1999 | CA2298107A1 Use of transcription factor brn-3a |
| 02/04/1999 | CA2298067A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 02/04/1999 | CA2298053A1 Novel estrogen receptor .beta. and isoforms |
| 02/04/1999 | CA2297907A1 Human estrogen receptor beta |
| 02/04/1999 | CA2297487A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 02/04/1999 | CA2297410A1 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | CA2297375A1 Ghrh expression system and methods of use |
| 02/04/1999 | CA2297328A1 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 02/04/1999 | CA2296292A1 Secreted proteins encoded by human chromosome 13 |
| 02/04/1999 | CA2239267A1 Novel compounds |
| 02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 02/03/1999 | EP0894862A2 Novel CysS |
| 02/03/1999 | EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894859A2 Asparaginyl tRNA synthetase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894858A2 Prolyl tRNA synthetase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894857A2 SecA gene from Streptococcus pneumoniae |
| 02/03/1999 | EP0894856A1 A human sMAD3 splice variant |
| 02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894853A1 Transcriptional silencer protein NRF, nucleic acid molecules encoding it and their use |
| 02/03/1999 | EP0894806A1 Novel pheS |
| 02/03/1999 | EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 02/03/1999 | EP0894140A1 Allele suppression |
| 02/03/1999 | EP0894139A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 02/03/1999 | EP0894137A1 Novel human myeloid terminal differentiation response gene |
| 02/03/1999 | EP0894133A2 Neuropeptide y receptor y5 and nucleic acid sequence |
| 02/03/1999 | EP0894132A2 Adam proteins and uses thereof |
| 02/03/1999 | EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 02/03/1999 | EP0894129A1 Short external guide sequences |
| 02/03/1999 | EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY |
| 02/03/1999 | EP0893950A1 Selective target cell activation by expression of a g protein-coupled receptor activated superiorly by synthetic ligand |
| 02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
| 02/03/1999 | CN1207123A (-)-strand RNA virus vector having autonomously replicating activity repliation autonome |
| 02/02/1999 | US5866755 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 02/02/1999 | US5866699 Oligonucleotides with anti-MDR-1 gene activity |
| 02/02/1999 | US5866696 Combination of vector and promoter can be used to introduce and express a human gene and correct a genetic defect in human cells resulting from malfunction of the mutant endogenous gene. |
| 02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
| 02/02/1999 | US5866553 Immune protection against infection |
| 02/02/1999 | US5866552 Tranducing muscle cells |
| 02/02/1999 | US5866551 Therapy for atherosclerosis |
| 02/02/1999 | US5866550 Method of inhibiting replication of hyperproliferative cells using a nucleic acid encoding EIA |
| 02/02/1999 | US5866546 Administering immunoregulator and cell proliferative agent |
| 02/02/1999 | US5866535 Forming antibodies |
| 02/02/1999 | US5866411 Genomic rna sequences |
| 02/02/1999 | US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus |
| 02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
| 02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
| 02/02/1999 | US5866369 Amps |
| 02/02/1999 | US5866366 gidB |
| 02/02/1999 | US5866362 Protein aggregates obtained by a process comprising culturing a host cell that expresses a desired protein in a medium comprising an effective amount of cu++ and wherein the desired protein forms inclusion bodies in the host cell. |
| 02/02/1999 | US5866340 Selective expression of desired genes in cells expressing oncoproteins |
| 02/02/1999 | US5866332 Diagnosis and treatment of disease states related to proliferation, specifically myeloproliferative diseases and leukemias. |
| 02/02/1999 | US5866329 Method and probe for detection of gene associated with liver neoplastic disease |
| 02/02/1999 | US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors |
| 02/02/1999 | US5865796 Gas driven gene delivery instrument |
| 02/01/1999 | CA2238672A1 Seca |
| 02/01/1999 | CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999004265A2 Cancer associated nucleic acids and polypeptides |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | WO1999004026A2 Lentiviral vectors |
| 01/28/1999 | WO1999004025A1 Improvements in or relating to expression of nucleic acid sequences in cerebellar cells |
| 01/28/1999 | WO1999004011A2 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | WO1999004010A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 01/28/1999 | WO1999004009A1 Method of dna vaccination using dna encoding antigen and encoding il6 |
| 01/28/1999 | WO1999004000A1 Adipocyte-specific protein homologs |
| 01/28/1999 | WO1999003999A1 Methods and compositions for inhibiting the proinflammatory response |
| 01/28/1999 | WO1999003998A1 Methods and compositions for tumor reduction |
| 01/28/1999 | WO1999003992A1 Trail receptor |
| 01/28/1999 | WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | WO1999003982A1 Interleukin-20 |
| 01/28/1999 | WO1999003980A1 Agm-derived stroma cells |
| 01/28/1999 | WO1999003973A1 Cardiac muscle regeneration using mesenchymal stem cells |
| 01/28/1999 | WO1999003890A1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 01/28/1999 | WO1999003889A1 Isolated dna encoding human calcium activated potassium channel |
| 01/28/1999 | WO1999003886A1 Tropoelastin derivatives |
| 01/28/1999 | WO1999003883A1 Compositions and methods based upon the tuberous sclerosis-1 (tsc1) gene and gene product |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003508A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 01/28/1999 | WO1999003506A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors |
| 01/28/1999 | WO1999003505A1 Gene therapy vehicle comprising dermal sheath tissue |